# Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent

> **NCT00361036** · PHASE1 · COMPLETED · sponsor: **Worthington-Kirsch, Robert L., M.D.** · enrollment: 44 (actual)

## Conditions studied

- Leiomyoma
- Leiomyomatosis
- Uterine Neoplasms

## Interventions

- **DEVICE:** Uterine fibroid embolization BeadBlock™
- **DEVICE:** Uterine fibroid embolization Embosphere®

## Key facts

- **NCT ID:** NCT00361036
- **Lead sponsor:** Worthington-Kirsch, Robert L., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361036, "Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00361036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*